Obesity/insulin resistance is associated with endothelial dysfunction: Implications for the syndrome of insulin resistance

Journal of Clinical Investigation

Volumn 97, Issue 11, 1996, Pages 2601-2610

  Steinberg, Helmut O ^b   Chaker, Haitham ^b   Leaming, Rosalind ^b   Johnson, Ann ^b   Brechtel, Ginger ^b   Baron, Alain D ^a  

^a INDIANA UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

Endothelium dependent vasodilation; Insulin resistance; Methacholine chloride; Obesity; Sodium nitroprusside

Indexed keywords

CHOLESTEROL; GLUCOSE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHACHOLINE; NITRIC OXIDE; NITROPRUSSIDE SODIUM;

ADULT; ARTICLE; ATHEROSCLEROSIS; BODY FAT; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; LEG BLOOD FLOW; MEAN ARTERIAL PRESSURE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; VASCULAR RESISTANCE; VASODILATATION;

EID: 0029977757     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118709     Document Type: Article

References (56)

1. Laakso, M., S.V. Edelman, G. Brechtel, and A.D. Baron. 1990. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese men. J. Clin. Invest. 85:1844-1852.
2. Baron, A.D., and G. Brechtel. 1993. Insulin differentially regulates systemic and skeletal muscle vascular resistance. Am. J. Physiol. Endocrinol. Metab. 265(28):E61-E67.
3. Anderson, E.A., R.P. Hoffman, T.W. Balon, C.A. Sinkey, and A.L. Mark. 1991. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J. Clin. Invest. 87:2246-2252.
4. Baron, A.D., G. Brechtel-Hook, A. Johnson, and D. Hardin. 1993. Skeletal muscle blood flow: a possible link between insulin resistance and blood pressure. Hypertension (Dallas). 21:129-135.
5. Baron, A.D., H. Steinberg, G. Brechtel, and A. Johnson. 1994. Skeletal muscle blood flow independently modulates insulin-mediated glucose uptake. Am. J. Physiol. 266:E248-E253.
6. Steinberg, H.O., G. Brechtel, A. Johnson, N. Fineberg, and A.D. Baron. 1994. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. J. Clin. Invest. 94:1172-1179.
7. Scherrer, U., D. Randin, P. Vollenweider, L. Vollenweider, and P. Nicod. 1994. Nitric oxide release accounts for insulin's vascular effects in humans. J. Clin. Invest. 94:2511-2515.
8. Ferrannini, E., G. Buzzigoli, R. Bonadonna, M. A. Giorico, M. Oleggini, L. Graciadei, R. Pedrinelli, L. Brandi, and S. Bevilacqua. 1987. Insulin resistance in essential hypertension. N. Engl. J. Med. 317:350-357.
9. McVeigh, G.E., G.M. Brennan, G.D. Johnston, B.J. McDermott, L.T. McGrath, J.W. Andrews, and J.R. Hayes. 1992. Impaired endothelium dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 35:771-776.
10. Shamiss, A., J. Carroll, and T. Rosenthal. 1992. Insulin resistance in secondary hypertension. Am. J. Hypertens. 5:26-28.
11. Calver, A., J. Collier, and P. Vallance. 1992. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J. Clin. Invest. 90:2548-2554.
12. Johnstone, M.T., S.J. Craeger, K.M. Scales, J.A. Cusco, B.K. Lee, and M.A. Craeger. 1993. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation. 88:2510-2516.
13. Reaven, G.M. 1993. Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu. Rev. Med. 44:131-141.
14. Reaven, G.M. 1988. Role of insulin resistance in human disease. Diabetes. 37:1595-1607.
15. Brozek, J., and A. Henschel. 1961. Techniques for measuring body composition: proceedings of a conference. In Conference on Techniques for Measuring Body Composition. National Academy of Sciences, National Research Council. Washington DC. 78-89.
16. National Diabetes Data Group. 1979. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 28:1039-1057.
17. Baron, A.D., G. Brechtel, P. Wallace, and S.V. Edelman. 1988. Rates and tissue sites of non-insulin and insulin-mediated glucose uptake in humans. Am. J. Physiol. 255:E769-E774.
18. Laakso, M., S.V. Edelman, G. Brechtel, and A.D. Baron. 1992. Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM. Diabetes. 41:1076-1083.
19. Kolterman, O.G., J. Insel, M. Saekow, and J.M. Olefsky. 1980. Mechanisms of insulin resistance in human obesity. Evidence for receptor and postreceptor defects. J. Clin. Invest. 65:1872-1884.
20. Rizza, R.A., J.L. Mandarino, and J.F. Gerich. 1981. Dose response characteristics for effects of insulin on glucose production and utilization in man. Am. J. Physiol. Endocrinol. Metab. 240(3):E630-E639.
21. Friedewald, W.T., R.T. Levy, and D.S. Fredrickson. 1972. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18:499-502.
22. Novak, M. 1965. Colormetric ultramicro method for the determination of free fatty acids. J. Lipid Res. 6:431-433.
23. Luscher, T.F. 1990. Functional abnormalities of the vascular endothelium in hypertension and atherosclerosis. Scand. J. Clin. Lab. Invest. 50(Suppl. 199):28-32.
24. Panza, J.A., A. Quyyumy, J.E. Brush, and S.E. Epstein. 1990. Abnormal endothelium dependent vascular relaxation in patients with essential hypertension. N. Engl. J. Med. 323:22-27.
25. Panza, J.A., P.R. Casino, D.M. Badar, and A.A. Quyyumi. 1993. Effect of increased availability of endothelium-derived-nitric-oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension. Circulation. 87:1475-1481.
26. Panza, J.A., P.R. Casino, C.M. Kilcoyne, and A.A. Quyyumi. 1993. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation. 87: 1468-1474.
27. Calver, A., J. Collier, S. Moncada, and P. Vallance. 1992. Effect of local intra- arterial NG-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal. J. Hypertens. 10:1025-1031.
28. Creager, M.A., J.P. Cooke, M.P. Mendelssohn, S.J. Gallagher, S.M. Coleman, J. Loscalzo, and V.J. Dzau. 1990. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J. Clin. Invest. 86:228-234.
29. Creager, M. A., S. J. Gallagher, X. J. Girerd, S. M. Coleman, V. J. Dzau, and J. P. Cooke. 1992. L-Arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J. Clin. Invest. 90:1248-1253.
30. Vallance, P., J. Collier, and S. Moncada. 1989. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet. ii:997-1000.
31. Radomski, M. W., R. M. J. Palmer, and S. Moncada. 1987. The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br. J. Pharmacol. 92:639-646.
32. Moncada, S., R. M. J. Palmer, and E. A. Higgs. 1988. The discovery of nitric oxide as the endogenous vasodilator. Hypertension (Dallas). 12:365-372.
33. Mollace, V., D. Salvemini, E. Anggard, and J. Vane. 1991. Nitric oxide from vascular smooth muscle cells: regulation of platelet reactivity and smooth muscle cell guanylate cyclase. Br. J. Pharmacol. 104:633-638.
34. Bruckdorfer, K. R., M. J. Jacobs, and C. Rice-Evans. 1990. Endothelium-derived relaxing factor (nitric oxide), lipoprotein oxidation and atherosclerosis. Biochem. Soc. Trans. 18:1061-1063.
35. Hogg, N., B. Kalyanaraman, J. Joseph, A. Struck, and S. Parthasarathy. 1993. Inhibition of low-density lipoprotein oxidation by nitric oxide. FEBS Lett. 334:170-174.
36. Jessup, W., and R. T. Dean. 1993. Autoinhibition of murine macrophage-mediated oxidation of low-density lipoprotein by nitric oxide synthesis. Atherosclerosis. 101:145-155.
37. Jessup, W. 1993. Cellular modification of low-density lipoproteins. Biochem. Soc. Trans. 21:321-325.
38. Ignarro, L.J. 1990. Nitric oxide: a novel signal transduction mechanism for transcellular communication. Hypertension (Dallas). 16:477-483.
39. Gupta, S., C. McArthur, C. Grady, and N.B. Ruderman. 1994. Stimulation of vascular Na-K-ATPase activity by nitric oxide: a cGMP-independent effeet. Am. J. Physiol. 266:H2146-H2151.
40. Luscher, T.F., Y. Dohi, and M. Tschudi. 1992. Endothelium-dependent regulation of resistance arteries: alterations with aging and hypertension. J. Cardiovasc. Pharmacol. 19(Suppl. 5):S34-S42.
41. Paterno, R., F.M. Faraci, and D.D. Heistad. 1994. Age-related changes in release of endothelium-derived relaxing factor from the carotid artery. Stroke. 25(12):2457-2460.
42. Takahashi, H., T. Nakanishi, M. Nishimura, H. Tanaka, and M. Yoshimura. 1992. Measurements of serum levels of nitrate ions in men and women: implications of endothelium-derived relaxing factor in blood pressure regulation and atherosclerosis. J. Cardiovasc. Pharmacol. 20(Suppl 12):S214-S216.
43. Taddei, S., A. Virdis, P. Matei, L. Ghiadoni, A. Gennari, C.B. Fasolo, I. Sudano, and A. Salvetti. 1995. Aging and endothelial function in normotensive subjects and patients with essential hypertension. Circulation. 91:1981-1987.
44. Groop, L.C., R.C. Bonadonna, D.C. Simonson, A.S. Petrides, M. Shank, and R.A. Defronzo. 1992. Effect of insulin on oxidative and nonoxidative pathways of free fatty acid metabolism in human obesity. Am. J. Physiol. 263: E79-E84.
45. Stepniakowski, K.T., T.L. Goodfriend, and B.M. Egan. 1995. Fatty acids enhance vascular alpha-adrenergic sensitivity. Hypertension (Dallas). 25:774-778.
46. Davda, R.K., K.T. Stepniakowski, G. Lu, M.E. Ullian, T.L. Goodfriend, and B.M. Egan. 1995. Oleic acid inhibits endothelial nitric oxide synthase by a protein kinase C-independent mechanism. Hypertension (Dallas). 26:764-770.
47. Chin, J.H., S. Azhar, and B.B. Hoffman. 1992. Inactivation of endothelial derived relaxing factor by oxidized lipoproteins. J. Clin. Invest. 89:10-18.
48. Liao, J.K., W.S. Shin, W.Y. Lee, and S.L. Clark. 1995. Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase. J. Biol. Chem. 270:319-324.
49. Reaven, G.M., Y.-D.I. Chen, J. Jeppesen, P. Maheux, and R.M. Krauss. 1993. Insulin resistance and hyperinsulinemia in individuals with small, dense, low density lipoprotein particles. J. Clin. Invest. 92:141-146.
50. Chait, A., R.L. Brazg, D.L. Tribble, and R.M. Krauss. 1993. Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B. Am. J. Med. 94: 350-356.
51. Cockcroft, J.R., P.J. Chowienczyk, N. Benjamin, and J.M. Ritter. 1994. Preserved endothelium-dependent vasodilation in patients with essential hypertension. N. Engl. J. Med. 330:1936-1940.
52. Dustan, H.P. 1985. Obesity and hypertension. Ann. Intern. Med. 103: 1047-1049.
53. Haffner, S.M., D.M. Braxton, R.A. Valdez, H.P. Hazuda, P.A. Morales, and M.P. Stern. 1992. Eight-year incidence of hypertension in Mexican-Americans and non-Hispanic-Whites. Am. J. Hypertens. 5:147-153.
54. Bjorntorp, P. 1990. Abdominal obesity and risk. Clin. Exp. Hypertens. A12(5):783-794.
55. Ferri, C., A. Carlomagno, S. Coassin, B. Roberta, M.R. Cassone Faldetta, O. Laurenti, G. Properzi, A. Santucci, and G. De Mattia. 1995. Circulating endothelin-1 levels increase during euglycemic hyperinsulinemic clamp in lean NIDDM men. Diabetes Care. 18:226-233.
56. Ferri, C., V. Pittoni, A. Piccoli, O. Laurenti, M.R. Cassone, C. Bellini, G. Properzi, G. Valesini, G. De Mattia, and A. Santucci. 1995. Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates its circulating levels in vivo. J. Clin. Endocrinol. & Metab. 80:829-835.